Identifying biosynthetic gene clusters whose products inhibit cystic fibrosis derived pathogens

Identifying biosynthetic gene clusters whose products inhibit cystic fibrosis derived pathogens

Bibliographic Details
Main Author:	Basalla, Joseph
Language:	English
Published:	Bowling Green State University / OhioLINK 2018
Subjects:	Biology Microbiology Molecular Biology Antibiotic resistance cystic fibrosis environmental microbiology Pseudomonas
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=bgsu1530795688583696

Similar Items

Environmental Pseudomonas are a source of Novel Antibiotics that inhibit Cystic fibrosis derived pathogenic Pseudomonas aeruginosa
by: Chatterjee, Payel
Published: (2017)

Microbiology of Upper Respiratory Tract Pathogens in Cystic Fibrosis Patients
by: Maryam Node Sharifi, et al.
Published: (2018-08-01)

Is the Potable Water System an Advantageous Preinfection Niche for Bacteria Colonizing the Cystic Fibrosis Lung?
by: Matthew J. Wargo
Published: (2019-06-01)

Diverse environmental Pseudomonas encode unique secondary metabolites that inhibit human pathogens
by: Davis, Elizabeth A.
Published: (2017)

Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis
by: Jeffrey M. Flynn, et al.
Published: (2020-04-01)

Identifying Gene Regions That Produce Antagonistic Factors Against Multidrug Resistant Pathogens
by: Crowl, Rachel A.
Published: (2021)

Mathematical Modeling of Pseudomonas aeruginosa Biofilm Growth and Treatment in the Cystic Fibrosis Lung
by: Miller, James Kyle
Published: (2012)

Nutritional modeling of bacterial infections : physiology and metabolism of Pseudomonas aeruginosa during growth in cystic fibrosis sputum
by: Palmer, Kelli Lea, 1981-
Published: (2012)

Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India
by: Balaji Arvind, et al.
Published: (2020-01-01)

Microbiological surveillance in patients with cystic fibrosis
by: Paola Gualdi, et al.
Published: (2010-06-01)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
by: Sheemal Shanista Kumar, et al.
Published: (2019-05-01)

Identification Of Genes Involved In The Production Of Novel Antimicrobial Products Capable Of Inhibiting Multi-Drug Resistant Pathogens
by: Harris, Ryan A.
Published: (2019)

Molecular typing and biological characteristics of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Brazil
by: Eliana Guedes Stehling, et al.

Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
by: M.C. Firmida, et al.
Published: (2016-01-01)

Comparison of virulence factors and antibiotic resistance of Pseudomonas aeruginosa strains isolated from patients with and without cystic fibrosis
by: Macin Salih, et al.
Published: (2017-10-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomes
by: Bodnár R, et al.
Published: (2016-02-01)

Is the type of chronic pulmonary infection a determinant of lung function outcomes in adult patients with cystic fibrosis?
by: A.J. Lopes, et al.
Published: (2015-12-01)

Evaluation of biofilm production by Pseudomonas Aeruginosa isolates recovered from cystic fibrosis and non-cystic fibrosis patients
by: L.R.R. Perez, et al.
Published: (2011-06-01)

Organisms isolated from adults with Cystic Fibrosis
by: Moore John E, et al.
Published: (2004-12-01)

Airway surface liquid antiviral activity in cystic fibrosis
by: Berkebile, Abigail Rae
Published: (2015)

Isolation and Characterization of Broad Host Range Phage that infect P. aeruginosa Pathogens
by: Wilburn, Kaylee Marie
Published: (2020)

Clinical significance of lung microbiota and efficiency of the inhaled antibacterial therapy of cystic fibrosis in children
by: E. V. Pavlinova, et al.
Published: (2019-03-01)

The Role of Bacteriocins in Mediating Interactions of Bacterial Isolates from Cystic Fibrosis Patients
by: Bakkal, Emine Suphan
Published: (2011)

Prevalence and antimicrobial susceptibility of respiratory pathogens in patients with cystic fibrosis
by: Vilma Almeida Paixão, et al.

Bicarbonate Inhibits Bacterial Growth and Biofilm Formation of Prevalent Cystic Fibrosis Pathogens
by: Orsolya Dobay, et al.
Published: (2018-09-01)

Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study
by: Julia C. Espel, et al.
Published: (2017-11-01)

Fibrosis quística: Diagnóstico tardío en el adulto presentación de caso Delayed diagnosis of the cystic fibrosis in adulthood: A case report
by: Mireya Fernández Fernández, et al.
Published: (2010-06-01)

Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study
by: Irene Bianconi, et al.
Published: (2019-01-01)

Metabolic Modeling of Cystic Fibrosis Airway Microbiota from Patient Samples
by: Vyas, Arsh
Published: (2021)

Isolation of Pseudomonas cepacia in cystic fibrosis patient
by: Elizabeth de Andrade Marques, et al.
Published: (1993-03-01)

COMPARISON OF EFFICACY AND TOXICITY OF TWO TOBRAMYCIN DOSING REGIMENS IN CYSTIC FIBROSIS.
by: Lund, Mary Ellen.
Published: (1983)

Oral Microbial Community Composition in Young Children with Cystic Fibrosis.
by: Bogdasarova, Karina
Published: (2014)

Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA
by: Nora Grahl, et al.
Published: (2018-08-01)

Study of biological characteristics of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis and from patients with extra-pulmonary infections
by: Eliana Guedes Stehling, et al.

Antibiotic resistance properties and molecular characterization of Pseudomonas aeruginosa strains from patients with cystic ﬁbrosis (CF) referred to Gholhak Pathobiology Laboratory in Tehran city during 2016-2018
by: Fahimeh Baghbani-Arani, et al.
Published: (2020-03-01)

Environmental Microbial Contamination during Cystic Fibrosis Group-Based Psychotherapy
by: Martina Rossitto, et al.
Published: (2021-01-01)

Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa
by: Jeffrey J. Bara, et al.
Published: (2018-01-01)

Colonização microbiana precoce de pacientes identificados por triagem neonatal para fibrose cística, com ênfase em Staphylococcus aureus Early microbial colonization of cystic fibrosis patients identified by neonatal screening, with emphasis on Staphylococcus aureus
by: Helena A. P. H. M. Souza, et al.
Published: (2006-10-01)

Molecular and Microbial Microenvironments in Chronically Diseased Lungs Associated with Cystic Fibrosis
by: Alexey V. Melnik, et al.
Published: (2019-09-01)

Cannot write session to /tmp/vufind_sessions/sess_clcrkd2o5p386scdprcofc1a5h